263 related articles for article (PubMed ID: 30476480)
1. Synchronous Oligometastatic Lung Cancer Deserves a Dedicated Management.
Loi M; Mazzella A; Mansuet-Lupo A; Bobbio A; Canny E; Magdeleinat P; Régnard JF; Damotte D; Trédaniel J; Alifano M
Ann Thorac Surg; 2019 Apr; 107(4):1053-1059. PubMed ID: 30476480
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
3. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
Johnson KK; Rosen JE; Salazar MC; Boffa DJ
Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
[TBL] [Abstract][Full Text] [Related]
6. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.
Parikh RB; Cronin AM; Kozono DE; Oxnard GR; Mak RH; Jackman DM; Lo PC; Baldini EH; Johnson BE; Chen AB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):880-7. PubMed ID: 24867533
[TBL] [Abstract][Full Text] [Related]
7. Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450).
De Ruysscher D; Wanders R; Hendriks LE; van Baardwijk A; Reymen B; Houben R; Bootsma G; Pitz C; van Eijsden L; Dingemans AC
J Thorac Oncol; 2018 Dec; 13(12):1958-1961. PubMed ID: 30253974
[TBL] [Abstract][Full Text] [Related]
8. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival.
Gray PJ; Mak RH; Yeap BY; Cryer SK; Pinnell NE; Christianson LW; Sher DJ; Arvold ND; Baldini EH; Chen AB; Kozono DE; Swanson SJ; Jackman DM; Alexander BM
Lung Cancer; 2014 Aug; 85(2):239-44. PubMed ID: 24974152
[TBL] [Abstract][Full Text] [Related]
9. Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery.
Congedo MT; Nachira D; Bertolaccini L; Chiappetta M; Zanfrini E; Meacci E; Vita ML; Lococo F; D'Argento E; Spaggiari L; Margaritora S
J Surg Oncol; 2022 Mar; 125(4):782-789. PubMed ID: 34918785
[TBL] [Abstract][Full Text] [Related]
10. Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis.
Toffart AC; Duruisseaux M; Brichon PY; Pirvu A; Villa J; Selek L; Guillem P; Dumas I; Ferrer L; Levra MG; Moro-Sibilot D
Ann Thorac Surg; 2018 Mar; 105(3):957-965. PubMed ID: 29397931
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
12. Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.
Xu Q; Zhou F; Liu H; Jiang T; Li X; Xu Y; Zhou C
J Thorac Oncol; 2018 Sep; 13(9):1383-1392. PubMed ID: 29852232
[TBL] [Abstract][Full Text] [Related]
13. Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.
Congedo MT; Cesario A; Lococo F; De Waure C; Apolone G; Meacci E; Cavuto S; Granone P
J Thorac Cardiovasc Surg; 2012 Aug; 144(2):444-52. PubMed ID: 22713303
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer.
Mazzella A; Loi M; Mansuet-Lupo A; Bobbio A; Blons H; Damotte D; Alifano M
Clin Lung Cancer; 2019 Nov; 20(6):405-411. PubMed ID: 31281051
[TBL] [Abstract][Full Text] [Related]
15. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
Kudelin N; Bölükbas S; Schirren J
Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
[TBL] [Abstract][Full Text] [Related]
16. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.
Ashworth A; Rodrigues G; Boldt G; Palma D
Lung Cancer; 2013 Nov; 82(2):197-203. PubMed ID: 24051084
[TBL] [Abstract][Full Text] [Related]
17. Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Juan O; Popat S
Clin Lung Cancer; 2017 Nov; 18(6):595-606. PubMed ID: 28377206
[TBL] [Abstract][Full Text] [Related]
18. A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis.
Spaggiari L; Bertolaccini L; Facciolo F; Gallina FT; Rea F; Schiavon M; Margaritora S; Congedo MT; Lucchi M; Ceccarelli I; Alloisio M; Bottoni E; Negri G; Carretta A; Cardillo G; Ricciardi S; Ruffini E; Costardi L; Muriana G; Viggiano D; Rusca M; Ventura L; Marulli G; De Palma A; Rosso L; Mendogni P; Crisci R; De Vico A; Maniscalco P; Tamburini N; Puma F; Ceccarelli S; Voltolini L; Bongiolatti S; Morelli A; Londero F
Lung Cancer; 2021 Apr; 154():29-35. PubMed ID: 33610120
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
20. Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
Chen XR; Hou X; Li DL; Sai K; Dinglin XX; Chen J; Wang N; Li MC; Wang KC; Chen LK
Clin Lung Cancer; 2021 Jan; 22(1):e25-e34. PubMed ID: 32839132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
